Non-alcoholic Fatty Liver Disease
📧 Sign up to get email alerts when something new happens for Non-alcoholic Fatty Liver Disease.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2018-03-06Clinical Trial Update: China Action on Spine and Hip Status
A completed clinical trial conducted by Beijing Jishuitan Hospital in China studied osteoporosis, non-alcoholic fatty liver disease, metabol…
-
CLINICAL_TRIALS trial_result · 2018-02-23Clinical Trial Update: Polyunsaturated Fatty Acids (PUFA) in Diabetic Fatty Liver [Phase 2]
Phase 2 trial evaluating polyunsaturated fatty acids for fatty liver in diabetes has completed, with results posted in 2018.
-
CLINICAL_TRIALS trial_result · 2018-02-23Clinical Trial Update: Impact of Short-term Fructose-enriched Diet on Serum Metabolome by Normal- and Over-weighed Women. [Phase 4]
Phase 4 trial assessing the impact of a short-term fructose-enriched diet on the serum metabolome in normal- and overweight women, in condit…
-
CLINICAL_TRIALS trial_result · 2018-01-30Clinical Trial Update: Comparing Effects of Liraglutide and Bariatric Surgery on Weight Loss, Liver Function, Body Composition, Insulin Resistance, Endothelial Function and Biomarkers of Non-alcoholic Steatohepatitis (NASH) in Obese Asian Adults [Phase 3]
A Phase 3 trial comparing liraglutide versus bariatric surgery for weight loss and metabolic endpoints in obese Asian adults with NAFLD/NASH…
-
CLINICAL_TRIALS trial_result · 2017-12-08Clinical Trial Update: Genetics of Fatty Liver Disease in Children
A completed Yale-sponsored clinical trial update examining genetic factors in pediatric non-alcoholic fatty liver disease.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2017-11-30Clinical Trial Update: Inflammation and Steatosis: the Role of Alpha-defensin
A clinical trial investigating the role of alpha-defensin in liver inflammation and fatty liver (steatosis); current status is not reported.
-
CLINICAL_TRIALS trial_result · 2017-11-01Clinical Trial Update: The Effects of PXR Activation on Hepatic Fat Content [Phase 4]
Phase 4 clinical trial investigating the effects of pregnane X receptor (PXR) activation on hepatic fat content in non-alcoholic fatty liver…
-
CLINICAL_TRIALS research · 2017-10-26Clinical Trial Update: Dietary Intervention and Intestinal Microbiota in Non-alcoholic Fatty Liver
A clinical trial update describing a dietary intervention and its impact on the intestinal microbiota in people with obesity and non-alcohol…
-
CLINICAL_TRIALS trial_result · 2017-09-25Clinical Trial Update: Efficacy of Oral Trigonella Foenum-graecum Seed Extract Vs Placebo in Treatment of None Alcoholic Fatty Liver Disease [Phase 2, Phase 3]
A clinical trial assessing oral Trigonella foenum-graecum seed extract versus placebo for non-alcoholic fatty liver disease has completed Ph…
-
CLINICAL_TRIALS withdrawal · 2017-08-30Clinical Trial Update: Diaphragmatic Breathing Exercise Improves Non-alcoholic Fatty Liver Disease [NA]
A clinical trial evaluating diaphragmatic breathing for non-alcoholic fatty liver disease has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2017-08-21Clinical Trial Update: A Study of EDP 305 in Healthy Subjects and Subjects With Presumptive NAFLD [Phase 1]
Phase 1 study of EDP 305 in healthy subjects and individuals with presumptive non-alcoholic fatty liver disease has completed.
-
CLINICAL_TRIALS research · 2017-08-16Clinical Trial Update: Effect of Non-alcoholic Fatty Liver Disease on Kidney Functions
This document reports on an ongoing clinical trial investigating the effect of non-alcoholic fatty liver disease on kidney function.
-
CLINICAL_TRIALS trial_result · 2017-08-15Clinical Trial Update: Serum Ferritin as a Non-invasive Marker in Prediction of Hepatic Fibrosis Among NAFLD Patients
A completed clinical trial evaluating whether serum ferritin can predict hepatic fibrosis in patients with non-alcoholic fatty liver disease…
-
CLINICAL_TRIALS trial_result · 2017-08-11Clinical Trial Update: Rifaximin Modify the Pathogenesis of Non-Alcoholic Fatty Liver Disease (NAFLD)
This update reports the completed clinical trial NCT02884037 sponsored by Mansoura University, evaluating rifaximin for modifying the pathog…
-
CLINICAL_TRIALS research · 2017-08-04Clinical Trial Update: An Observational Cohort Study Evaluating Fatty Liver Disease and Liver Fibrosis in Moderate to Severe Psoriasis
This source describes an observational cohort study sponsored by King's College London to evaluate fatty liver disease and liver fibrosis in…
-
CLINICAL_TRIALS trial_result · 2017-08-03Clinical Trial Update: Mediterranean Lifestyle Intervention in Patients With Non-alcoholic Fatty Liver Disease [NA]
A completed clinical trial evaluating a Mediterranean lifestyle intervention in patients with non-alcoholic fatty liver disease (NAFLD) and …
-
CLINICAL_TRIALS research · 2017-07-28Clinical Trial Update: Measurement of Alanine Aminotransaminase (ALT) Following Initiation of Antidiabetic Agents in Patients With Type 2 Diabetes in a Real-world Clinical Setting: a Retrospective Cohort Study
This completed retrospective cohort study evaluated ALT changes after initiation of antidiabetic therapy in adults with type 2 diabetes, inc…
-
CLINICAL_TRIALS withdrawal · 2017-07-28Clinical Trial Update: Improving Insulin Resistance To Treat Non-Alcoholic Fatty Liver Disease: A Pilot Study [Phase 1]
A Phase 1 pilot trial aiming to improve insulin resistance to treat non-alcoholic fatty liver disease has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2017-07-27Clinical Trial Update: Prospective, Cross-sectional and Multicenter Study, Evaluating the Diagnosis Accuracy of the Controlled Attenuation Parameter(CAP) Measured by FibroScan® (Either With M+ or XL+ Probe) in Patient With Non-Alcoholic Fatty Liver Disease Using Liver Biopsy as Reference. [NA]
This completed multicenter prospective study assessed the diagnostic accuracy of CAP measurements by FibroScan (M+ or XL+ probes) for non-al…
-
CLINICAL_TRIALS trial_result · 2017-07-27Clinical Trial Update: Nutritional Prevention of Diabetes Mellitus Type 2 [NA]
This completed clinical trial evaluates nutritional prevention strategies for Type 2 Diabetes Mellitus and assesses effects on liver fat and…
-
CLINICAL_TRIALS trial_result · 2017-07-27Clinical Trial Update: Magnetic Resonance Imaging (MRI) Fat Quantification of the Liver [NA]
This update notes that a clinical trial evaluating MRI-based quantification of liver fat has completed at University Hospital Basel, focusin…
-
CLINICAL_TRIALS research · 2017-07-11Clinical Trial Update: NAFLD: Independent Effects of Western Dietary Pattern Profile and Sedentary Life [NA]
This completed clinical trial evaluated the independent effects of a Western dietary pattern and sedentary lifestyle on non-alcoholic fatty …
-
CLINICAL_TRIALS trial_result · 2017-06-29Clinical Trial Update: Response of NAFLD Patients to Mediterranean Diet [NA]
A completed clinical trial evaluated how patients with non-alcoholic fatty liver disease respond to a Mediterranean diet.
-
CLINICAL_TRIALS trial_result · 2017-06-23Clinical Trial Update: Effects of Ipragliflozin on Excessive Fat in Type 2 Diabetes Patients With Non-alcoholic Fatty Liver Disease Treated With Metformin and Pioglitazone [Phase 4]
Phase 4 study evaluating ipragliflozin on excess fat in people with type 2 diabetes and non-alcoholic fatty liver disease who are on metform…
-
CLINICAL_TRIALS trial_result · 2017-06-16Clinical Trial Update: Non-invasive Liver Screening for Risk Assessment for Coronary Heart Disease
A completed clinical trial from the University of Leipzig evaluating non-invasive liver screening as a risk assessment tool for coronary hea…